UKHCDO Guidelines – Archive
The table below provides information on where UKHCDO Guidelines have been published and, where applicable, links to the publisher’s website from where the document can be downloaded (in Adobe Acrobat format); these are denoted as “PDF”.
A list of other relevant publications can be found on the ‘Other Publications’ page – click here to visit
A list archived guidelines can be found on the ‘Current Guidelines’ – click here to visit
You may also download guidelines for working parties and research & publication from the links below
UKHCDO Guidelines for Research & Publication 
Procedure For UKHCDO Guidelines 
| Year | Ref | Title | Journal | Review Date | Document |
|---|---|---|---|---|---|
| 2015 | UKHCDO document, pending publication | UKHCDO protocol for first line immune tolerance induction for children with severe haemophilia A | N/A | Nov 2018 | |
| 2011 | Haemophilia, 17, e877-883 | UKHCDO guidelines on the management of HCV in patients with hereditary bleeding disorders 2011. | Haemophilia | TBC | |
| 2008 | Haemophilia, 14, 1099-1111 | The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organisation Haemophilia Genetics Laboratory Network | Haemophilia | TBC | |
| 2008 | Haemophilia, 14, 671-684 | Guideline on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. A United Kingdom Haemophilia Center Doctors’ Organisation (UKHCDO) guideline approved by the British Committee for Standards in Haematology | Haemophilia | September 2013 | |
| 2006 | Br J Haematol, 133, 591-605 | The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation | British Journal of Haematology | TBC | |
| 2006 | Haemophilia, 12, 301-336 | The obstetric and gynaecological management of women with inherited bleeding disorders-review with guidelines produced by a taskforce of UK Haemophilia Centre Doctors’ Organization | Haemophilia | TBC | |
| 2005 | Haemophilia, 11, 145-163 | A framework for genetic service provision for haemophilia and other inherited bleeding disorders | Haemophilia | TBC | |
| 2005 | Haemophilia, 11, 387-397 | The molecular analysis of haemophilia A: a guideline from the UK Haemophilia Centre Doctors’ Organisation Haemophilia Genetics Laboratory Network | Haemophilia | NA | |
| 2005 | Haemophilia, 11, 398-404 | The molecular analysis of haemophilia B: a guideline from the UK Haemophilia Centre Doctors’ Organisation Haemophilia Genetics Laboratory Network | Haemophilia | NA | |
| 2004 | Haemophilia, 10, 593-628 | The rare coagulation disorders–review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation | Haemophilia | TBC | |
| 2004 | Haemophilia, 10, 218-231 | Management of von Willebrand’s disease: a guideline from the UK Haemophilia Centre Doctors’ Organisation | Haemophilia | TBC | |
| 2004 | Haemophilia, 10, 199-217 | The diagnosis of von Willebrand’s disease: a guideline from the UK Haemophilia Centre Doctors’ Organisation | Haemophilia | TBC | |
| 2003 | Haemophilia (2003), 9, 1-23 | Guidelines on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders | Haemophilia | NA | |
| 2002 | Pathophysiol Haemost Thromb. 2002;32 Suppl 1:19-21 | The 2000 United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) inhibitor guidelines | Pathophysiology of Haemostasis and Thrombosis (PMID 12214141) | NA | |
| 2001 | Haemophilia (2001), 7, 339-345 | Guidelines on the diagnosis, management and prevention of hepatitis in haemophilia | Haemophilia | NA | |
| 1995 | Haemophilia (1995), 1, (Suppl.4),42-44 | Guideline on the diagnosis and management of chronic liver disease in haemophilia | Haemophilia | NA |